The latest edition of the publication "Mindfield - The Bulletin of the Parapsychological Association" devotes some of its pages to the BIAL Foundation, highlighting it contribution to the study and research in parapsychology.
The BIAL Group officially inaugurated its new Integrated Unit of Production and Research, located in the Science and Technology Park of Biscay,
In Bilbao, Spain. The official opening ceremony was chaired by His Royal Highness the Prince of Asturias, counting also with the presence of personalities of the Portuguese and Spanish Government-and other institutional representatives of the Basque Country.
The new antiepileptic drug from the BIAL Group has just been launched in Greece and in the Republic of Ireland after reaching reimbursement agreements. The launch in these markets comes under the license agreement and co-promotion signed between BIAL and the multinational Eisai, in February 2009, for marketing the drug in several European countries.
Zebinix® (eslicarbazepine acetate), an add-on (adjunctive) therapy for adults with partial-onset seizures, with or without secondary generalisation (where the seizure spreads to both sides of the brain), has been launched today in Spain by Eisai and BIAL in a co-promotion.